Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study
Clinical trial NCT07084259 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07084259
- Sponsor
- Hanyang University Seoul Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2030-06-01
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.